Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C20H24N2O2S |
| Molecular Weight | 356.482 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCN(CC)CCNC1=CC=C(CO)C2=C1C(=O)C3=C(S2)C=CC=C3
InChI
InChIKey=MFZWMTSUNYWVBU-UHFFFAOYSA-N
InChI=1S/C20H24N2O2S/c1-3-22(4-2)12-11-21-16-10-9-14(13-23)20-18(16)19(24)15-7-5-6-8-17(15)25-20/h5-10,21,23H,3-4,11-13H2,1-2H3
| Molecular Formula | C20H24N2O2S |
| Molecular Weight | 356.482 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Hycanthone is a thioxanthene derivative of lucanthone with anti-schistosomal activity and potential antineoplastic activity. It was clinically available for the treatment of human schistosomiasis. Anti-helmintic action relies on its ability to inhibit worm monoamine oxidase and cholinesterases. Hycanthone produced immediate side effects such as hepatotoxicity and gastrointestinal disturbances, and was consequently withdrawn. Hycanthone inhibits apurinic endonuclease-1 (APE1) by direct protein binding. Hycanthone was used in the 1980s as antitumor agents, it was pulled out of Phase II trials.
Originator
Sources: https://patents.google.com/patent/US3312598
Curator's Comment: reference retrieved from www.drugfuture.com/chemdata/hycanthone.html
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: UniProtKB: Q71SU7 (Carboxylic ester hydrolase) |
|||
Target ID: GO:0097621 Sources: https://www.ncbi.nlm.nih.gov/pubmed/7229816 |
|||
Target ID: CHEMBL5619 Sources: https://www.ncbi.nlm.nih.gov/pubmed/21935361 |
80.0 nM [IC50] |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Curative | Hycanthone Approved Usehuman schistosomiasis |
|||
| Primary | Unknown Approved UseUnknown |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Screening of a chemical library reveals novel PXR-activating pharmacologic compounds. | 2015-01-05 |
|
| RNA interference in Schistosoma mansoni schistosomula: selectivity, sensitivity and operation for larger-scale screening. | 2010-10-19 |
|
| Identification of novel p53 pathway activating small-molecule compounds reveals unexpected similarities with known therapeutic agents. | 2010-09-27 |
|
| Reduced susceptibility to praziquantel among naturally occurring Kenyan isolates of Schistosoma mansoni. | 2009-08-18 |
|
| Drug discovery for schistosomiasis: hit and lead compounds identified in a library of known drugs by medium-throughput phenotypic screening. | 2009-07-14 |
|
| Mefloquine--an aminoalcohol with promising antischistosomal properties in mice. | 2009 |
|
| The NIH-NIAID schistosomiasis resource center. | 2008-07-30 |
|
| Prediction of genotoxicity of chemical compounds by statistical learning methods. | 2005-06 |
|
| Long-term hepatocellular effects of hycanthone and of two other anti-Schistosomal drugs in mice infected with Schistosoma mansoni. | 1976-06 |
Patents
Sample Use Guides
Human schistosomiasis: single intramuscular dose (3.0, 2.5, 2.0, 1.5, and 1.0 mg/kg body weight).Unresectable pancreatic cancer: hycanthone was administered 60 mg/m2 intravenously within 2 to 4 hr during each day of the 5-day course of infusions during the first and fifth weeks of radiation therapy.
Route of Administration:
Other
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1190369
Hycanthone stimulates motor activity of Schistosoma mansoni at concentrations of 10(-6) to 10(-5) M, and partially blocks the paralytic effects of carbachol and physostigmine.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:41:53 GMT 2025
by
admin
on
Mon Mar 31 18:41:53 GMT 2025
|
| Record UNII |
2BXX5EVN2A
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C250
Created by
admin on Mon Mar 31 18:41:53 GMT 2025 , Edited by admin on Mon Mar 31 18:41:53 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
2BXX5EVN2A
Created by
admin on Mon Mar 31 18:41:53 GMT 2025 , Edited by admin on Mon Mar 31 18:41:53 GMT 2025
|
PRIMARY | |||
|
221-463-7
Created by
admin on Mon Mar 31 18:41:53 GMT 2025 , Edited by admin on Mon Mar 31 18:41:53 GMT 2025
|
PRIMARY | |||
|
1383
Created by
admin on Mon Mar 31 18:41:53 GMT 2025 , Edited by admin on Mon Mar 31 18:41:53 GMT 2025
|
PRIMARY | |||
|
52768
Created by
admin on Mon Mar 31 18:41:53 GMT 2025 , Edited by admin on Mon Mar 31 18:41:53 GMT 2025
|
PRIMARY | |||
|
HYCANTHONE
Created by
admin on Mon Mar 31 18:41:53 GMT 2025 , Edited by admin on Mon Mar 31 18:41:53 GMT 2025
|
PRIMARY | |||
|
DTXSID9023128
Created by
admin on Mon Mar 31 18:41:53 GMT 2025 , Edited by admin on Mon Mar 31 18:41:53 GMT 2025
|
PRIMARY | |||
|
134434
Created by
admin on Mon Mar 31 18:41:53 GMT 2025 , Edited by admin on Mon Mar 31 18:41:53 GMT 2025
|
PRIMARY | |||
|
142982
Created by
admin on Mon Mar 31 18:41:53 GMT 2025 , Edited by admin on Mon Mar 31 18:41:53 GMT 2025
|
PRIMARY | |||
|
100000084172
Created by
admin on Mon Mar 31 18:41:53 GMT 2025 , Edited by admin on Mon Mar 31 18:41:53 GMT 2025
|
PRIMARY | |||
|
2207
Created by
admin on Mon Mar 31 18:41:53 GMT 2025 , Edited by admin on Mon Mar 31 18:41:53 GMT 2025
|
PRIMARY | |||
|
D006826
Created by
admin on Mon Mar 31 18:41:53 GMT 2025 , Edited by admin on Mon Mar 31 18:41:53 GMT 2025
|
PRIMARY | |||
|
3634
Created by
admin on Mon Mar 31 18:41:53 GMT 2025 , Edited by admin on Mon Mar 31 18:41:53 GMT 2025
|
PRIMARY | |||
|
DB14061
Created by
admin on Mon Mar 31 18:41:53 GMT 2025 , Edited by admin on Mon Mar 31 18:41:53 GMT 2025
|
PRIMARY | |||
|
CHEMBL22077
Created by
admin on Mon Mar 31 18:41:53 GMT 2025 , Edited by admin on Mon Mar 31 18:41:53 GMT 2025
|
PRIMARY | |||
|
SUB08057MIG
Created by
admin on Mon Mar 31 18:41:53 GMT 2025 , Edited by admin on Mon Mar 31 18:41:53 GMT 2025
|
PRIMARY | |||
|
m6068
Created by
admin on Mon Mar 31 18:41:53 GMT 2025 , Edited by admin on Mon Mar 31 18:41:53 GMT 2025
|
PRIMARY | Merck Index | ||
|
C550
Created by
admin on Mon Mar 31 18:41:53 GMT 2025 , Edited by admin on Mon Mar 31 18:41:53 GMT 2025
|
PRIMARY | |||
|
3105-97-3
Created by
admin on Mon Mar 31 18:41:53 GMT 2025 , Edited by admin on Mon Mar 31 18:41:53 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT | |||
|
|
SALT/SOLVATE -> PARENT | |||
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |